Cefozopran
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)- 2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin- 4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 113359-04-9 |
| ATC code | J01DE03 |
| PubChem | CID 9571080 |
| ChemSpider | 7845546 |
| UNII | 1LG87K28LW |
| KEGG | D01052 |
| ChEMBL | CHEMBL1276663 |
| Chemical data | |
| Formula | C19H17N9O5S2 |
| Mol. mass | 515.52 g/mol |
|
|
|
|
| |
|
Cefozopran (INN) is a fourth-generation cephalosporin.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |